Results 91 to 100 of about 28,442 (301)
Defibrillation is the only effective treatment for ventricular fibrillation (VF). Optimal methods for defibrillation in children are derived and extrapolated from adult data. VF occurs as the initial rhythm in 8-20% of pediatric cardiac arrests. This has fostered a new interest in determining the optimal technique for pediatric defibrillation.
Haskell Sarah, Atkins Dianne
openaire +3 more sources
FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran +10 more
wiley +1 more source
Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach
Genetic insights into the risk assessment of sudden cardiac events. ABSTRACT Sudden cardiac events are the leading cause of death worldwide. Conventional risk stratification methods, which largely depend on clinical history, imaging, and electrocardiography, are usually inadequate for identifying high‐risk individuals, especially those without visible ...
Shrikant Verma +5 more
wiley +1 more source
The impact of cardiac resynchronization therapy with implantable cardioverter defibrillators on patients with moderate to severe chronic heart failure: A single-arm clinical trial [PDF]
Background: Patients with moderate to severe chronic heart failure (CHF) are at high risk for cardiac mortality. Cardiac resynchronization therapy with defibrillators (CRT-D) as a potentially beneficial option can improve the clinical outcomes of such ...
Hossein Salehi Omran +7 more
doaj
Highlights of primary prevention of death in patients with ventricular arrhythmias (VA) are discussed. Overview of all main clinical trials exploring various anti-arrhythmic drugs in prevention of death in patients with VA is presented.
Yu. A. Bunin
doaj +1 more source
The Ethics of Deactivating Implanted Cardioverter Defibrillators
Implantable cardioverter defibrillators are life-saving devices for many patients with cardiac disease. Recipients of these devices, nevertheless, often suffer from progressive comorbid and cardiac conditions.
Berger, Jeffrey T., Jeffrey T. Berger
core +1 more source
Abstract Health‐related social needs (HRSN) significantly influence patient outcomes, yet they are rarely integrated into point‐of‐care decision‐making. We developed a process to embed HRSN‐informed and HRSN‐targeted care recommendations directly into three electronic health record‐integrated high‐use clinical pathways—cirrhosis, diabetes, and ...
Karthik Warke Rohatgi +5 more
wiley +1 more source
Sudden cardiac death remains the global burden. The most common associated arrhythmia is ventricular fibrillation. From current guidelines, defibrillation is the most critical step to rescue the cardiac arrest victims.
Peerawut Deeprasertkul +2 more
doaj +1 more source
Reuse of cardiac pacemakers and implantable cardioverter defibrillators
Risk analysis, technical feasibility, regulatory and ethical aspects related to the reuse of cardiac pacemakers and implantable cardioverter ...
Eliane Molina Psaltikidis +2 more
core +1 more source
This study investigated how radiographers assess radiographic image quality using the think‐aloud technique. It reveals that image quality assessment is shaped by both technical standards and subjective, contextual factors, including patient condition and interprofessional dynamics. This highlights the importance of balancing standardised criteria with
Robin Decoster +3 more
wiley +1 more source

